Literature DB >> 22800507

3,3'-Diindolylmethane, but not indole-3-carbinol, inhibits histone deacetylase activity in prostate cancer cells.

Laura M Beaver1, Tian-Wei Yu, Elizabeth I Sokolowski, David E Williams, Roderick H Dashwood, Emily Ho.   

Abstract

Increased consumption of cruciferous vegetables is associated with a reduced risk of developing prostate cancer. Indole-3-carbinol (I3C) and 3,3'-diindolylmethane (DIM) are phytochemicals derived from cruciferous vegetables that have shown promise in inhibiting prostate cancer in experimental models. Histone deacetylase (HDAC) inhibition is an emerging target for cancer prevention and therapy. We sought to examine the effects of I3C and DIM on HDACs in human prostate cancer cell lines: androgen insensitive PC-3 cells and androgen sensitive LNCaP cells. I3C modestly inhibited HDAC activity in LNCaP cells by 25% but no inhibition of HDAC activity was detected in PC-3 cells. In contrast, DIM significantly inhibited HDAC activity in both cell lines by as much as 66%. Decreases in HDAC activity correlated with increased expression of p21, a known target of HDAC inhibitors. DIM treatment caused a significant decrease in the expression of HDAC2 protein in both cancer cell lines but no significant change in the protein levels of HDAC1, HDAC3, HDAC4, HDAC6 or HDAC8 was detected. Taken together, these results show that inhibition of HDAC activity by DIM may contribute to the phytochemicals' anti-proliferative effects in the prostate. The ability of DIM to target aberrant epigenetic patterns, in addition to its effects on detoxification of carcinogens, may make it an effective chemopreventive agent by targeting multiple stages of prostate carcinogenesis. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22800507      PMCID: PMC3428467          DOI: 10.1016/j.taap.2012.07.007

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  43 in total

1.  Acid reaction products of indole-3-carbinol and their effects on cytochrome P450 and phase II enzymes in rat and monkey hepatocytes.

Authors:  H M Wortelboer; C A de Kruif; A A van Iersel; H E Falke; J Noordhoek; B J Blaauboer
Journal:  Biochem Pharmacol       Date:  1992-04-01       Impact factor: 5.858

Review 2.  Cruciferous vegetables intake and risk of prostate cancer: a meta-analysis.

Authors:  Ben Liu; Qiqi Mao; Min Cao; Liping Xie
Journal:  Int J Urol       Date:  2011-11-28       Impact factor: 3.369

3.  Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells.

Authors:  S R Chinni; Y Li; S Upadhyay; P K Koppolu; F H Sarkar
Journal:  Oncogene       Date:  2001-05-24       Impact factor: 9.867

4.  Plant-derived 3,3'-Diindolylmethane is a strong androgen antagonist in human prostate cancer cells.

Authors:  Hien T Le; Charlene M Schaldach; Gary L Firestone; Leonard F Bjeldanes
Journal:  J Biol Chem       Date:  2003-03-27       Impact factor: 5.157

5.  A novel mechanism of chemoprotection by sulforaphane: inhibition of histone deacetylase.

Authors:  Melinda C Myzak; P Andrew Karplus; Fung-Lung Chung; Roderick H Dashwood
Journal:  Cancer Res       Date:  2004-08-15       Impact factor: 12.701

6.  Physiological modeling of formulated and crystalline 3,3'-diindolylmethane pharmacokinetics following oral administration in mice.

Authors:  Mark J Anderton; Margaret M Manson; Richard Verschoyle; Andreas Gescher; William P Steward; Marion L Williams; Donald E Mager
Journal:  Drug Metab Dispos       Date:  2004-06       Impact factor: 3.922

7.  Therapeutic activity of 3,3'-diindolylmethane on prostate cancer in an in vivo model.

Authors:  Maya Nachshon-Kedmi; Fuad A Fares; Shmuel Yannai
Journal:  Prostate       Date:  2004-10-01       Impact factor: 4.104

8.  Upregulation and nuclear recruitment of HDAC1 in hormone refractory prostate cancer.

Authors:  Kalipso Halkidou; Luke Gaughan; Susan Cook; Hing Y Leung; David E Neal; Craig N Robson
Journal:  Prostate       Date:  2004-05-01       Impact factor: 4.104

9.  Pharmacokinetics and tissue disposition of indole-3-carbinol and its acid condensation products after oral administration to mice.

Authors:  Mark J Anderton; Margaret M Manson; Richard D Verschoyle; Andreas Gescher; John H Lamb; Peter B Farmer; William P Steward; Marion L Williams
Journal:  Clin Cancer Res       Date:  2004-08-01       Impact factor: 12.531

10.  Induction of apoptosis in human prostate cancer cell line, PC3, by 3,3'-diindolylmethane through the mitochondrial pathway.

Authors:  M Nachshon-Kedmi; S Yannai; F A Fares
Journal:  Br J Cancer       Date:  2004-10-04       Impact factor: 7.640

View more
  33 in total

1.  Epigenetic modifications of Nrf2 by 3,3'-diindolylmethane in vitro in TRAMP C1 cell line and in vivo TRAMP prostate tumors.

Authors:  Tien-Yuan Wu; Tin Oo Khor; Zheng-Yuan Su; Constance Lay-Lay Saw; Limin Shu; Ka-Lung Cheung; Ying Huang; Siwang Yu; Ah-Ng Tony Kong
Journal:  AAPS J       Date:  2013-05-09       Impact factor: 4.009

Review 2.  Phytochemicals from cruciferous vegetables, epigenetics, and prostate cancer prevention.

Authors:  Gregory W Watson; Laura M Beaver; David E Williams; Roderick H Dashwood; Emily Ho
Journal:  AAPS J       Date:  2013-06-26       Impact factor: 4.009

3.  IL6-induced metastasis modulators p-STAT3, MMP-2 and MMP-9 are targets of 3,3'-diindolylmethane in ovarian cancer cells.

Authors:  Minghua Zou; Xianquan Zhang; Changhua Xu
Journal:  Cell Oncol (Dordr)       Date:  2015-10-28       Impact factor: 6.730

4.  Transcriptome analysis reveals a dynamic and differential transcriptional response to sulforaphane in normal and prostate cancer cells and suggests a role for Sp1 in chemoprevention.

Authors:  Laura M Beaver; Alex Buchanan; Elizabeth I Sokolowski; Allison N Riscoe; Carmen P Wong; Jeff H Chang; Christiane V Löhr; David E Williams; Roderick H Dashwood; Emily Ho
Journal:  Mol Nutr Food Res       Date:  2014-08-05       Impact factor: 5.914

Review 5.  Impact of Epigenetic Dietary Components on Cancer through Histone Modifications.

Authors:  Yifeng Gao; Trygve O Tollefsbol
Journal:  Curr Med Chem       Date:  2015       Impact factor: 4.530

6.  Long noncoding RNAs and sulforaphane: a target for chemoprevention and suppression of prostate cancer.

Authors:  Laura M Beaver; Rachael Kuintzle; Alex Buchanan; Michelle W Wiley; Sarah T Glasser; Carmen P Wong; Gavin S Johnson; Jeff H Chang; Christiane V Löhr; David E Williams; Roderick H Dashwood; David A Hendrix; Emily Ho
Journal:  J Nutr Biochem       Date:  2017-01-12       Impact factor: 6.048

7.  The phytochemical 3,3'-diindolylmethane decreases expression of AR-controlled DNA damage repair genes through repressive chromatin modifications and is associated with DNA damage in prostate cancer cells.

Authors:  Zoraya Palomera-Sanchez; Gregory W Watson; Carmen P Wong; Laura M Beaver; David E Williams; Roderick H Dashwood; Emily Ho
Journal:  J Nutr Biochem       Date:  2017-05-25       Impact factor: 6.048

Review 8.  Histone and Non-Histone Targets of Dietary Deacetylase Inhibitors.

Authors:  Eunah Kim; William H Bisson; Christiane V Löhr; David E Williams; Emily Ho; Roderick H Dashwood; Praveen Rajendran
Journal:  Curr Top Med Chem       Date:  2016       Impact factor: 3.295

Review 9.  Natural compound-derived epigenetic regulators targeting epigenetic readers, writers and erasers.

Authors:  Anne Yuqing Yang; Hyuck Kim; Wenji Li; Ah-Ng Tony Kong
Journal:  Curr Top Med Chem       Date:  2016       Impact factor: 3.295

Review 10.  Epigenetics of breast cancer: Modifying role of environmental and bioactive food compounds.

Authors:  Donato F Romagnolo; Kevin D Daniels; Jonathan T Grunwald; Stephan A Ramos; Catherine R Propper; Ornella I Selmin
Journal:  Mol Nutr Food Res       Date:  2016-06       Impact factor: 5.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.